APO Research
Talk to an analyst

APO RESEARCH · REPORT

Primaquine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Primaquine Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchPrimaquine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Primaquine Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Primaquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primaquine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Primaquine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Primaquine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Primaquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Primaquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Primaquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Primaquine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Primaquine include Cyper Pharma, Santa Cruz Biotechnology, Summit Medical Group and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Primaquine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Primaquine, also provides the sales of main regions and countries. Of the upcoming market potential for Primaquine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Primaquine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Primaquine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Primaquine sales, projected growth trends, production technology, application and end-user industry.

Primaquine Segment by Company

Cyper Pharma

Santa Cruz Biotechnology

Summit Medical Group

Pfizer

Primaquine Segment by Type

Injectables Primaquine

Tablets Primaquine

Capsules Primaquine

Primaquine Segment by Application

Laboratory

Hospital

Clinic

Others

Primaquine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primaquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Primaquine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Primaquine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Primaquine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injectables Primaquine Major Manufacturers Table 3. Tablets Primaquine Major Manufacturers Table 4. Capsules Primaquine Major Manufacturers Table 5. Global Primaquine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Laboratory Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Primaquine Industry Trends Table 11. Primaquine Industry Drivers Table 12. Primaquine Industry Opportunities and Challenges Table 13. Primaquine Industry Restraints Table 14. Global Primaquine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Primaquine Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Primaquine Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Primaquine Revenue Market Share by Region (2021-2026) Table 18. Global Primaquine Revenue Market Share by Region (2027-2032) Table 19. Global Primaquine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Primaquine Sales by Region (2021-2026) & (K Units) Table 21. Global Primaquine Sales by Region (2027-2032) & (K Units) Table 22. Global Primaquine Sales Market Share by Region (2021-2026) Table 23. Global Primaquine Sales Market Share by Region (2027-2032) Table 24. Global Primaquine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Primaquine Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Primaquine Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Primaquine Sales Market Share by Manufacturers (2021-2026) Table 28. Global Primaquine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Primaquine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Primaquine Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Primaquine Manufacturers, Product Type & Application Table 32. Global Primaquine Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Primaquine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Primaquine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Primaquine Revenue Market Share by Type (2021-2026) Table 39. Global Primaquine Revenue Market Share by Type (2027-2032) Table 40. Global Primaquine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Primaquine Sales by Type (2021-2026) & (K Units) Table 42. Global Primaquine Sales by Type (2027-2032) & (K Units) Table 43. Global Primaquine Sales Market Share by Type (2021-2026) Table 44. Global Primaquine Sales Market Share by Type (2027-2032) Table 45. Global Primaquine Price by Type (2021-2026) & (US$/Unit) Table 46. Global Primaquine Price by Type (2027-2032) & (US$/Unit) Table 47. Global Primaquine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Primaquine Revenue Market Share by Application (2021-2026) Table 51. Global Primaquine Revenue Market Share by Application (2027-2032) Table 52. Global Primaquine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Primaquine Sales by Application (2021-2026) & (K Units) Table 54. Global Primaquine Sales by Application (2027-2032) & (K Units) Table 55. Global Primaquine Sales Market Share by Application (2021-2026) Table 56. Global Primaquine Sales Market Share by Application (2027-2032) Table 57. Global Primaquine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Primaquine Price by Application (2027-2032) & (US$/Unit) Table 59. Cyper Pharma Company Information Table 60. Cyper Pharma Business Overview Table 61. Cyper Pharma Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Cyper Pharma Primaquine Product Portfolio Table 63. Cyper Pharma Recent Development Table 64. Santa Cruz Biotechnology Company Information Table 65. Santa Cruz Biotechnology Business Overview Table 66. Santa Cruz Biotechnology Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Santa Cruz Biotechnology Primaquine Product Portfolio Table 68. Santa Cruz Biotechnology Recent Development Table 69. Summit Medical Group Company Information Table 70. Summit Medical Group Business Overview Table 71. Summit Medical Group Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Summit Medical Group Primaquine Product Portfolio Table 73. Summit Medical Group Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pfizer Primaquine Product Portfolio Table 78. Pfizer Recent Development Table 79. North America Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Primaquine Sales by Type (2021-2026) & (K Units) Table 82. North America Primaquine Sales by Type (2027-2032) & (K Units) Table 83. North America Primaquine Sales Price by Type (2021-2026) & (US$/Unit) Table 84. North America Primaquine Sales Price by Type (2027-2032) & (US$/Unit) Table 85. North America Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Primaquine Sales by Application (2021-2026) & (K Units) Table 88. North America Primaquine Sales by Application (2027-2032) & (K Units) Table 89. North America Primaquine Sales Price by Application (2021-2026) & (US$/Unit) Table 90. North America Primaquine Sales Price by Application (2027-2032) & (US$/Unit) Table 91. North America Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Primaquine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Primaquine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Primaquine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 95. North America Primaquine Sales by Country (2021-2026) & (K Units) Table 96. North America Primaquine Sales by Country (2027-2032) & (K Units) Table 97. North America Primaquine Sales Price by Country (2021-2026) & (US$/Unit) Table 98. North America Primaquine Sales Price by Country (2027-2032) & (US$/Unit) Table 99. United States Primaquine Revenue (2021-2032) & (US$ Million) Table 100. Canada Primaquine Revenue (2021-2032) & (US$ Million) Table 101. Mexico Primaquine Revenue (2021-2032) & (US$ Million) Table 102. Europe Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Primaquine Sales by Type (2021-2026) & (K Units) Table 105. Europe Primaquine Sales by Type (2027-2032) & (K Units) Table 106. Europe Primaquine Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe Primaquine Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Primaquine Sales by Application (2021-2026) & (K Units) Table 111. Europe Primaquine Sales by Application (2027-2032) & (K Units) Table 112. Europe Primaquine Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe Primaquine Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Primaquine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Primaquine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Primaquine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. Europe Primaquine Sales by Country (2021-2026) & (K Units) Table 119. Europe Primaquine Sales by Country (2027-2032) & (K Units) Table 120. Europe Primaquine Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe Primaquine Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany Primaquine Revenue (2021-2032) & (US$ Million) Table 123. France Primaquine Revenue (2021-2032) & (US$ Million) Table 124. U.K. Primaquine Revenue (2021-2032) & (US$ Million) Table 125. Italy Primaquine Revenue (2021-2032) & (US$ Million) Table 126. Russia Primaquine Revenue (2021-2032) & (US$ Million) Table 127. Spain Primaquine Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Primaquine Revenue (2021-2032) & (US$ Million) Table 129. Switzerland Primaquine Revenue (2021-2032) & (US$ Million) Table 130. Sweden Primaquine Revenue (2021-2032) & (US$ Million) Table 131. Poland Primaquine Revenue (2021-2032) & (US$ Million) Table 132. China Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 133. China Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 134. China Primaquine Sales by Type (2021-2026) & (K Units) Table 135. China Primaquine Sales by Type (2027-2032) & (K Units) Table 136. China Primaquine Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China Primaquine Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 139. China Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 140. China Primaquine Sales by Application (2021-2026) & (K Units) Table 141. China Primaquine Sales by Application (2027-2032) & (K Units) Table 142. China Primaquine Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China Primaquine Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Primaquine Sales by Type (2021-2026) & (K Units) Table 147. Asia Primaquine Sales by Type (2027-2032) & (K Units) Table 148. Asia Primaquine Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia Primaquine Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Primaquine Sales by Application (2021-2026) & (K Units) Table 153. Asia Primaquine Sales by Application (2027-2032) & (K Units) Table 154. Asia Primaquine Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia Primaquine Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Primaquine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Primaquine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Primaquine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia Primaquine Sales by Country (2021-2026) & (K Units) Table 161. Asia Primaquine Sales by Country (2027-2032) & (K Units) Table 162. Asia Primaquine Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia Primaquine Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan Primaquine Revenue (2021-2032) & (US$ Million) Table 165. South Korea Primaquine Revenue (2021-2032) & (US$ Million) Table 166. India Primaquine Revenue (2021-2032) & (US$ Million) Table 167. Australia Primaquine Revenue (2021-2032) & (US$ Million) Table 168. Taiwan Primaquine Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Primaquine Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Primaquine Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Primaquine Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Primaquine Sales by Type (2021-2026) & (K Units) Table 173. SAMEA Primaquine Sales by Type (2027-2032) & (K Units) Table 174. SAMEA Primaquine Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA Primaquine Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA Primaquine Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Primaquine Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Primaquine Sales by Application (2021-2026) & (K Units) Table 179. SAMEA Primaquine Sales by Application (2027-2032) & (K Units) Table 180. SAMEA Primaquine Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA Primaquine Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Primaquine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Primaquine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Primaquine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA Primaquine Sales by Country (2021-2026) & (K Units) Table 187. SAMEA Primaquine Sales by Country (2027-2032) & (K Units) Table 188. SAMEA Primaquine Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA Primaquine Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil Primaquine Revenue (2021-2032) & (US$ Million) Table 191. Argentina Primaquine Revenue (2021-2032) & (US$ Million) Table 192. Chile Primaquine Revenue (2021-2032) & (US$ Million) Table 193. Colombia Primaquine Revenue (2021-2032) & (US$ Million) Table 194. Peru Primaquine Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Primaquine Revenue (2021-2032) & (US$ Million) Table 196. Israel Primaquine Revenue (2021-2032) & (US$ Million) Table 197. UAE Primaquine Revenue (2021-2032) & (US$ Million) Table 198. Turkey Primaquine Revenue (2021-2032) & (US$ Million) Table 199. Iran Primaquine Revenue (2021-2032) & (US$ Million) Table 200. Egypt Primaquine Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Primaquine Distributors List Table 204. Primaquine Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Primaquine Image Figure 2. Global Primaquine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primaquine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injectables Primaquine Image Figure 5. Tablets Primaquine Image Figure 6. Capsules Primaquine Image Figure 7. Global Primaquine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Primaquine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Laboratory Image Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Primaquine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Primaquine Revenue (2021-2032) & (US$ Million) Figure 15. Global Primaquine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Primaquine Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Primaquine Revenue Market Share by Region (2021-2032) Figure 18. Global Primaquine Sales (2021-2032) & (K Units) Figure 19. Global Primaquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Primaquine Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Primaquine Sales YoY (2021-2032) & (K Units) Figure 22. Europe Primaquine Sales YoY (2021-2032) & (K Units) Figure 23. China Primaquine Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Primaquine Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Primaquine Sales YoY (2021-2032) & (K Units) Figure 26. Global Primaquine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Primaquine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Primaquine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Primaquine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Primaquine Revenue Market Share by Type (2021-2032) Figure 32. Global Primaquine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Primaquine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Primaquine Sales Market Share by Type (2021-2032) Figure 35. Global Primaquine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Primaquine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Primaquine Revenue Market Share by Application (2021-2032) Figure 38. Global Primaquine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Primaquine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Primaquine Sales Market Share by Application (2021-2032) Figure 41. North America Primaquine Revenue Share by Type (2021-2032) Figure 42. North America Primaquine Sales Share by Type (2021-2032) Figure 43. North America Primaquine Revenue Share by Application (2021-2032) Figure 44. North America Primaquine Sales Share by Application (2021-2032) Figure 45. North America Primaquine Revenue Share by Country (2021-2032) Figure 46. North America Primaquine Sales Share by Country (2021-2032) Figure 47. Europe Primaquine Revenue Share by Type (2021-2032) Figure 48. Europe Primaquine Sales Share by Type (2021-2032) Figure 49. Europe Primaquine Revenue Share by Application (2021-2032) Figure 50. Europe Primaquine Sales Share by Application (2021-2032) Figure 51. Europe Primaquine Revenue Share by Country (2021-2032) Figure 52. Europe Primaquine Sales Share by Country (2021-2032) Figure 53. China Primaquine Revenue Share by Type (2021-2032) Figure 54. China Primaquine Sales Share by Type (2021-2032) Figure 55. China Primaquine Revenue Share by Application (2021-2032) Figure 56. China Primaquine Sales Share by Application (2021-2032) Figure 57. Asia Primaquine Revenue Share by Type (2021-2032) Figure 58. Asia Primaquine Sales Share by Type (2021-2032) Figure 59. Asia Primaquine Revenue Share by Application (2021-2032) Figure 60. Asia Primaquine Sales Share by Application (2021-2032) Figure 61. Asia Primaquine Revenue Share by Country (2021-2032) Figure 62. Asia Primaquine Sales Share by Country (2021-2032) Figure 63. SAMEA Primaquine Revenue Share by Type (2021-2032) Figure 64. SAMEA Primaquine Sales Share by Type (2021-2032) Figure 65. SAMEA Primaquine Revenue Share by Application (2021-2032) Figure 66. SAMEA Primaquine Sales Share by Application (2021-2032) Figure 67. SAMEA Primaquine Revenue Share by Country (2021-2032) Figure 68. SAMEA Primaquine Sales Share by Country (2021-2032) Figure 69. Primaquine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Primaquine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables Primaquine
  • Tablets Primaquine
  • Capsules Primaquine
Applications
  • Laboratory
  • Hospital
  • Clinic
  • Others
Companies covered
  • Cyper Pharma
  • Santa Cruz Biotechnology
  • Summit Medical Group
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Primaquine Market by Type
  3. 1.2.1 Global Primaquine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injectables Primaquine
  5. 1.2.3 Tablets Primaquine
  6. 1.2.4 Capsules Primaquine
  7. 1.3 Primaquine Market by Application
  8. 1.3.1 Global Primaquine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Laboratory
  10. 1.3.3 Hospital
  11. 1.3.4 Clinic
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Primaquine Market Dynamics
  1. 2.1 Primaquine Industry Trends
  2. 2.2 Primaquine Industry Drivers
  3. 2.3 Primaquine Industry Opportunities and Challenges
  4. 2.4 Primaquine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Primaquine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Primaquine Revenue by Region
  3. 3.2.1 Global Primaquine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Primaquine Revenue by Region (2021-2026)
  5. 3.2.3 Global Primaquine Revenue by Region (2027-2032)
  6. 3.2.4 Global Primaquine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Primaquine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Primaquine Sales by Region
  9. 3.4.1 Global Primaquine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Primaquine Sales by Region (2021-2026)
  11. 3.4.3 Global Primaquine Sales by Region (2027-2032)
  12. 3.4.4 Global Primaquine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Primaquine Revenue by Manufacturers
  2. 4.1.1 Global Primaquine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Primaquine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Primaquine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Primaquine Sales by Manufacturers
  6. 4.2.1 Global Primaquine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Primaquine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Primaquine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Primaquine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Primaquine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Primaquine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Primaquine Manufacturers, Product Type & Application
  13. 4.7 Global Primaquine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Primaquine Market CR5 and HHI
  16. 4.8.2 2025 Primaquine Tier 1, Tier 2, and Tier 3
5 Primaquine Market by Type
  1. 5.1 Global Primaquine Revenue by Type
  2. 5.1.1 Global Primaquine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Primaquine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Primaquine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Primaquine Sales by Type
  6. 5.2.1 Global Primaquine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Primaquine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Primaquine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Primaquine Price by Type
6 Primaquine Market by Application
  1. 6.1 Global Primaquine Revenue by Application
  2. 6.1.1 Global Primaquine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Primaquine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Primaquine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Primaquine Sales by Application
  6. 6.2.1 Global Primaquine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Primaquine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Primaquine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Primaquine Price by Application
7 Company Profiles
  1. 7.1 Cyper Pharma
  2. 7.1.1 Cyper Pharma Company Information
  3. 7.1.2 Cyper Pharma Business Overview
  4. 7.1.3 Cyper Pharma Primaquine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Cyper Pharma Primaquine Product Portfolio
  6. 7.1.5 Cyper Pharma Recent Developments
  7. 7.2 Santa Cruz Biotechnology
  8. 7.2.1 Santa Cruz Biotechnology Company Information
  9. 7.2.2 Santa Cruz Biotechnology Business Overview
  10. 7.2.3 Santa Cruz Biotechnology Primaquine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Santa Cruz Biotechnology Primaquine Product Portfolio
  12. 7.2.5 Santa Cruz Biotechnology Recent Developments
  13. 7.3 Summit Medical Group
  14. 7.3.1 Summit Medical Group Company Information
  15. 7.3.2 Summit Medical Group Business Overview
  16. 7.3.3 Summit Medical Group Primaquine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Summit Medical Group Primaquine Product Portfolio
  18. 7.3.5 Summit Medical Group Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Primaquine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Primaquine Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Primaquine Market Size by Type
  2. 8.1.1 North America Primaquine Revenue by Type (2021-2032)
  3. 8.1.2 North America Primaquine Sales by Type (2021-2032)
  4. 8.1.3 North America Primaquine Price by Type (2021-2032)
  5. 8.2 North America Primaquine Market Size by Application
  6. 8.2.1 North America Primaquine Revenue by Application (2021-2032)
  7. 8.2.2 North America Primaquine Sales by Application (2021-2032)
  8. 8.2.3 North America Primaquine Price by Application (2021-2032)
  9. 8.3 North America Primaquine Market Size by Country
  10. 8.3.1 North America Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Primaquine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Primaquine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Primaquine Market Size by Type
  2. 9.1.1 Europe Primaquine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Primaquine Sales by Type (2021-2032)
  4. 9.1.3 Europe Primaquine Price by Type (2021-2032)
  5. 9.2 Europe Primaquine Market Size by Application
  6. 9.2.1 Europe Primaquine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Primaquine Sales by Application (2021-2032)
  8. 9.2.3 Europe Primaquine Price by Application (2021-2032)
  9. 9.3 Europe Primaquine Market Size by Country
  10. 9.3.1 Europe Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Primaquine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Primaquine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Primaquine Market Size by Type
  2. 10.1.1 China Primaquine Revenue by Type (2021-2032)
  3. 10.1.2 China Primaquine Sales by Type (2021-2032)
  4. 10.1.3 China Primaquine Price by Type (2021-2032)
  5. 10.2 China Primaquine Market Size by Application
  6. 10.2.1 China Primaquine Revenue by Application (2021-2032)
  7. 10.2.2 China Primaquine Sales by Application (2021-2032)
  8. 10.2.3 China Primaquine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Primaquine Market Size by Type
  2. 11.1.1 Asia Primaquine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Primaquine Sales by Type (2021-2032)
  4. 11.1.3 Asia Primaquine Price by Type (2021-2032)
  5. 11.2 Asia Primaquine Market Size by Application
  6. 11.2.1 Asia Primaquine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Primaquine Sales by Application (2021-2032)
  8. 11.2.3 Asia Primaquine Price by Application (2021-2032)
  9. 11.3 Asia Primaquine Market Size by Country
  10. 11.3.1 Asia Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Primaquine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Primaquine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Primaquine Market Size by Type
  2. 12.1.1 SAMEA Primaquine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Primaquine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Primaquine Price by Type (2021-2032)
  5. 12.2 SAMEA Primaquine Market Size by Application
  6. 12.2.1 SAMEA Primaquine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Primaquine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Primaquine Price by Application (2021-2032)
  9. 12.3 SAMEA Primaquine Market Size by Country
  10. 12.3.1 SAMEA Primaquine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Primaquine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Primaquine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Primaquine Value Chain Analysis
  2. 13.1.1 Primaquine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Primaquine Production Mode & Process
  6. 13.2 Primaquine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Primaquine Distributors
  9. 13.2.3 Primaquine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst